References
- ArnoldLMCroffordLJMartinSAThe effect of anxiety and depression on improvements in pain in a randomized, controlled trial of pregabalin for treatment of fibromyalgiaPain Med20078633818028041
- ArnoldLMLuYCroffordLJA double-blind, multicenter trial comparing duloxetine with placebo in the treatment of fibromyalgia patients with or without major depressive disorderArthritis Rheum20045029748415457467
- ArnoldLMRosenAPritchettYLA randomized, double-blind, placebo-controlled trial of duloxetine in the treatment of women with fibromyalgia with or without major depressive disorderPain200511951516298061
- BennettRMJonesJTurkDCAn internet survey of 2,596 people with fibromyalgiaBMC Musculoskelet Disord200782717349056
- BoonenAvan den HeuvelRvan TubergenALarge differences in cost of illness and wellbeing between patients with fibromyalgia, chronic low back pain, or ankylosing spondylitisAnn Rheum Dis20056439640215271773
- BymasterFPDreshfield-AhmadLJThrelkeldPGComparative affinity of duloxetine and venlafaxine for serotonin and norepinephrine transporters in vitro and in vivo, human serotonin receptor subtypes, and other neuronal receptorsNeuropsychopharmacology2001258718011750180
- CarvilleSFArendt-NielsenSBliddalHEULAR evidence based recommendations for the management of fibromyalgia syndromeAnn Rheum Dis2008675364117644548
- CroffordLJRowbothamMCMeasePJPregabalin for the treatment of fibromyalgia syndrome: results of a randomized, double-blind, placebo-controlled trialArthritis Rheum20055212647315818684
- DetkeMJLuYGoldsteinDJDuloxetine, 60 mg once daily, for major depressive disorder: a randomized double-blind placebo-controlled trialJ Clin Psychiatry2002633081512000204
- GoldenbergDSmithNFibromyalgia, rheumatologists, and the medical literature: a shaky allianceJ Rheumatol200330151312508405
- GoldenbergDLBurckhardtCCroffordLManagement of fibromyalgia syndromeJama200429223889515547167
- GoldsteinDJLuYDetkeMJEffects of duloxetine on painful physical symptoms associated with depressionPsychosomatics200445172814709757
- GoldsteinDJLuYDetkeMJDuloxetine vs. placebo in patients with painful diabetic neuropathyPain20051161091815927394
- GoldsteinDJMallinckrodtCLuYDuloxetine in the treatment of major depressive disorder: a double-blind clinical trialJ Clin Psychiatry2002632253111926722
- GranJTThe epidemiology of chronic generalized musculoskeletal painBest Pract Res Clin Rheumatol2003175476112849711
- HenrikssonCMLiedbergGMGerdleBWomen with fibromyalgia: work and rehabilitationDisabil Rehabil2005276859416012061
- JadadARMooreRACarrollDAssessing the quality of reports of randomized clinical trials: is blinding necessary?Control Clin Trials1996171128721797
- MillanMJDescending control of painProg Neurobiol20026635547412034378
- PenrodJRBernatskySAdamVHealth services costs and their determinants in women with fibromyalgiaJ Rheumatol2004311391815229962
- RaskinJPritchettYLWangFA double-blind, randomized multicenter trial comparing duloxetine with placebo in the management of diabetic peripheral neuropathic painPain Med200563465616266355
- RobinsonRLJonesMLIn search of pharmacoeconomic evaluations for fibromyalgia treatments: a reviewExpert Opin Pharmacother2006710273916722813
- van KoulilSEfftingMKraaimaatFWCognitive-behavioural therapies and exercise programmes for patients with fibromyalgia: state of the art and future directionsAnn Rheum Dis2007665718116916856
- VittonOGendreauMGendreauJA double-blind placebo-controlled trial of milnacipran in the treatment of fibromyalgiaHum Psychopharmacol200419Suppl 1S273515378666
- WhiteKPSpeechleyMHarthMThe London Fibromyalgia Epidemiology Study: direct health care costs of fibromyalgia syndrome in London, CanadaJ Rheumatol199926885910229411
- WolfeFRossKAndersonJThe prevalence and characteristics of fibromyalgia in the general populationArthritis Rheum19953819287818567
- WolfeFSmytheHAYunusMBThe American College of Rheumatology 1990 Criteria for the Classification of Fibromyalgia. Report of the Multicenter Criteria CommitteeArthritis Rheum199033160722306288